{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:59:32Z","timestamp":1789790372696,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4-6","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12672-019-00367-0","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:24:43Z","timestamp":1567074283000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Metastatic Adrenocortical Carcinoma: a Single Institutional Experience"],"prefix":"10.1007","volume":"10","author":[{"given":"Dwight H.","family":"Owen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Phay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Abdel-Misih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Konda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"issue":"1","key":"367_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","volume":"169","author":"L Ng","year":"2003","unstructured":"Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169(1):5\u201311","journal-title":"J Urol"},{"issue":"5","key":"367_CR2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","volume":"30","author":"E Kebebew","year":"2006","unstructured":"Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30(5):872\u2013878","journal-title":"World J Surg"},{"issue":"1","key":"367_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.010","volume":"351","author":"JD Wasserman","year":"2012","unstructured":"Wasserman JD, Zambetti GP, Malkin D (2012) Towards an understanding of the role of P53 in adrenocortical carcinogenesis. Mol Cell Endocrinol 351(1):101\u2013110","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"367_CR4","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","volume":"72","author":"MD Wooten","year":"1993","unstructured":"Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer. 72(11):3145\u20133155","journal-title":"Cancer."},{"issue":"11","key":"367_CR5","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","volume":"113","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer. 113(11):3130\u20133136","journal-title":"Cancer."},{"issue":"2","key":"367_CR6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (2014) Adrenocortical carcinoma. Endocr Rev 35(2):282\u2013326","journal-title":"Endocr Rev"},{"issue":"23","key":"367_CR7","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","volume":"356","author":"M Terzolo","year":"2007","unstructured":"Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356(23):2372\u20132380","journal-title":"N Engl J Med"},{"issue":"4","key":"367_CR8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jc.2016-2894","volume":"102","author":"A Berruti","year":"2017","unstructured":"Berruti A, Grisanti S, Pulzer A, Claps M, Daffara F, Loli P, Mannelli M, Boscaro M, Arvat E, Tiberio G, Hahner S, Zaggia B, Porpiglia F, Volante M, Fassnacht M, Terzolo M (2017) Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma. J Clin Endocrinol Metab 102(4):1358\u20131365","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"367_CR9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2010.04.030","volume":"80","author":"A Sabolch","year":"2011","unstructured":"Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E (2011) Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys 80(5):1477\u20131484","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"367_CR10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/jc.2012-2367","volume":"98","author":"MA Habra","year":"2013","unstructured":"Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R (2013) A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98(1):192\u2013197","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"367_CR11","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","volume":"91","author":"M Fassnacht","year":"2006","unstructured":"Fassnacht M, Hahner S, Polat B, Koschker A-C, Kenn W, Flentje M, Allolio B (2006) Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metabol 91(11):4501\u20134504","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"367_CR12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1590\/s1677-5538.ibju.2017.0095","volume":"43","author":"V Srougi","year":"2017","unstructured":"Srougi V, Bessa J, Tanno FY, Ferreira AM, Hoff AO, Bezerra JE et al (2017) Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: are we offering the best? Int Braz J Urol 43(5):841\u2013848","journal-title":"Int Braz J Urol"},{"key":"367_CR13","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1210\/jc.2019-00029","volume":"104","author":"LA Gharzai","year":"2019","unstructured":"Gharzai LA, Green MD, Griffith KA, Else T, Mayo CS, Hesseltine E, Spratt DE, Ben-Josef E, Sabolch A, Miller BS, Worden F, Giordano TJ, Hammer GD, Jolly S (2019) Adjuvant radiation improves recurrence-free survival and overall survival in adrenocortical carcinoma. J Clin Endocrinol Metab 104:3743\u20133750","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"367_CR14","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1245\/s10434-018-6510-x","volume":"25","author":"DW Nelson","year":"2018","unstructured":"Nelson DW, Chang SC, Bandera BC, Fischer TD, Wollman R, Goldfarb M (2018) Adjuvant radiation is associated with improved survival for select patients with non-metastatic adrenocortical carcinoma. Ann Surg Oncol 25(7):2060\u20132066","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"367_CR15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Lib\u00e9 R, Ardito A, al Ghuzlan A, Quinkler M, O\u00dfwald A, Ronchi CL, de Krijger R, Feelders RA, Waldmann J, Willenberg HS, Deutschbein T, Stell A, Reincke M, Papotti M, Baudin E, Tissier F, Haak HR, Loli P, Terzolo M, Allolio B, M\u00fcller HH, Fassnacht M (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100(3):841\u2013849","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"367_CR16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","volume":"366","author":"M Fassnacht","year":"2012","unstructured":"Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardi\u00e8re C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, M\u00fcller HH, Skogseid B (2012) Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med 366(23):2189\u20132197","journal-title":"N Engl J Med"},{"issue":"12","key":"367_CR17","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","volume":"26","author":"S Aubert","year":"2002","unstructured":"Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M, Leteurtre E (2002) Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26(12):1612\u20131619","journal-title":"Am J Surg Pathol"},{"key":"367_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","volume":"62","author":"E Duregon","year":"2017","unstructured":"Duregon E, Cappellesso R, Maffeis V, Zaggia B, Ventura L, Berruti A, Terzolo M, Fassina A, Volante M, Papotti M (2017) Validation of the prognostic role of the \"Helsinki Score\" in 225 cases of adrenocortical carcinoma. Hum Pathol 62:1\u20137","journal-title":"Hum Pathol"},{"issue":"3","key":"367_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","volume":"8","author":"LM Weiss","year":"1984","unstructured":"Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8(3):163\u2013169","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"367_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","volume":"13","author":"LM Weiss","year":"1989","unstructured":"Weiss LM, Medeiros LJ, Vickery AL Jr (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13(3):202\u2013206","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"367_CR21","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A, de Krijger R et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179(4):G1\u2013g46","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"367_CR22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jvir.2010.05.020","volume":"21","author":"J Cazejust","year":"2010","unstructured":"Cazejust J, De Baere T, Auperin A, Deschamps F, Hechelhammer L, Abdel-Rehim M et al (2010) Transcatheter arterial chemoembolization for liver metastases in patients with adrenocortical carcinoma. J Vasc Interv Radiol 21(10):1527\u20131532","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"367_CR23","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1245\/s10434-011-1564-z","volume":"18","author":"RT Ripley","year":"2011","unstructured":"Ripley RT, Kemp CD, Davis JL, Langan RC, Royal RE, Libutti SK, Steinberg SM, Wood BJ, Kammula US, Fojo T, Avital I (2011) Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol 18(7):1972\u20131979","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"367_CR24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000200804","volume":"82","author":"H Soga","year":"2009","unstructured":"Soga H, Takenaka A, Ooba T, Nakano Y, Miyake H, Takeda M, Tanaka K, Hara I, Fujisawa M (2009) A twelve-year experience with adrenal cortical carcinoma in a single institution: long-term survival after surgical treatment and transcatheter arterial embolization. Urol Int 82(2):222\u2013226","journal-title":"Urol Int"},{"issue":"4","key":"367_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejca.2009.12.007","volume":"46","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, Bud\u00e4us L, Shariat SF, Guazzoni G, Montorsi F, Karakiewicz PI (2010) The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer 46(4):713\u2013719","journal-title":"Eur J Cancer"},{"issue":"10","key":"367_CR26","first-page":"2817","volume":"18","author":"S Wang","year":"2017","unstructured":"Wang S, Chen SS, Gao WC, Bai L, Luo L, Zheng XG, Luo Y (2017) Prognostic factors of adrenocortical carcinoma: an analysis of the surveillance epidemiology and end results (Seer) database. Asian Pac J Cancer Prev 18(10):2817\u20132823","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"367_CR27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12885-017-3506-z","volume":"17","author":"J Baur","year":"2017","unstructured":"Baur J, Buntemeyer TO, Megerle F, Deutschbein T, Spitzweg C, Quinkler M et al (2017) Outcome after resection of adrenocortical carcinoma liver metastases: a retrospective study. BMC Cancer 17(1):522","journal-title":"BMC Cancer"},{"issue":"8","key":"367_CR28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jso.24439","volume":"114","author":"TB Tran","year":"2016","unstructured":"Tran TB, Postlewait LM, Maithel SK, Prescott JD, Wang TS, Glenn J, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Hatzaras I, Shenoy R, Pawlik TM, Norton JA, Poultsides GA (2016) Actual 10-year survivors following resection of adrenocortical carcinoma. J Surg Oncol 114(8):971\u2013976","journal-title":"J Surg Oncol"},{"issue":"1","key":"367_CR29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-015-4803-x","volume":"23","author":"GA Margonis","year":"2016","unstructured":"Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK et al (2016) Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes. Ann Surg Oncol 23(1):134\u2013141","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"367_CR30","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1210\/jc.2017-01624","volume":"102","author":"JEK Henning","year":"2017","unstructured":"Henning JEK, Deutschbein T, Altieri B, Steinhauer S, Kircher S, Sbiera S, Wild V, Schl\u00f6telburg W, Kroiss M, Perotti P, Rosenwald A, Berruti A, Fassnacht M, Ronchi CL (2017) Gemcitabine-based chemotherapy in adrenocortical carcinoma: a multicenter study of efficacy and predictive factors. J Clin Endocrinol Metab 102(11):4323\u20134332","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"367_CR31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/ERC-09-0281","volume":"17","author":"P Sperone","year":"2010","unstructured":"Sperone P, Ferrero A, Daffara F, Priola A, Zaggia B, Volante M, Santini D, Vincenzi B, Badalamenti G, Intrivici C, del Buono S, de Francia S, Kalomirakis E, Ratti R, Angeli A, Dogliotti L, Papotti M, Terzolo M, Berruti A (2010) Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-\/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. Endocr Relat Cancer 17(2):445\u2013453","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"367_CR32","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00259-014-2834-3","volume":"41","author":"S Takeuchi","year":"2014","unstructured":"Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL Jr, Macapinlac HA et al (2014) Impact of (1)(8)F-Fdg Pet\/Ct on the management of adrenocortical carcinoma: analysis of 106 patients. Eur J Nucl Med Mol Imaging 41(11):2066\u20132073","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"367_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","volume":"169","author":"M Ayala-Ramirez","year":"2013","unstructured":"Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA (2013) Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169(6):891\u2013899","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"367_CR34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","volume":"65","author":"A Berruti","year":"2014","unstructured":"Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M (2014) Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Eur Urol 65(4):832\u2013838","journal-title":"Eur Urol"},{"issue":"6","key":"367_CR35","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/liv.12750","volume":"35","author":"FT Kolligs","year":"2015","unstructured":"Kolligs FT, Bilbao JI, Jakobs T, Inarrairaegui M, Nagel JM, Rodriguez M et al (2015) Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma. Liver Int 35(6):1715\u20131721","journal-title":"Liver Int"},{"issue":"3","key":"367_CR36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1245\/s10434-014-4164-x","volume":"22","author":"A Saxena","year":"2015","unstructured":"Saxena A, Meteling B, Kapoor J, Golani S, Morris DL, Bester L (2015) Is Yttrium-90 Radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients. Ann Surg Oncol 22(3):794\u2013802","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"367_CR37","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2967\/jnumed.113.135855","volume":"55","author":"Z Devcic","year":"2014","unstructured":"Devcic Z, Rosenberg J, Braat AJ, Techasith T, Banerjee A, Sze DY et al (2014) The Efficacy of hepatic 90y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis. J Nucl Med 55(9):1404\u20131410","journal-title":"J Nucl Med"},{"issue":"3","key":"367_CR38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","volume":"31","author":"AS Kennedy","year":"2008","unstructured":"Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RRP, Liu D, Palmedo H, Overton C, Jones B, Salem R (2008) Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90y-microspheres: early results in 148 patients. Am J Clin Oncol 31(3):271\u2013279","journal-title":"Am J Clin Oncol"},{"key":"367_CR39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12957-015-0551-4","volume":"13","author":"LA Shirley","year":"2015","unstructured":"Shirley LA, McNally M, Chokshi R, Jones N, Tassone P, Guy G et al (2015) Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review. World J Surg Oncol 13:167","journal-title":"World J Surg Oncol"},{"issue":"5","key":"367_CR40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, Hammer GD, Giordano TJ, Verhaak RGW, Zheng S, Verhaak RGW, Giordano TJ, Hammer GD, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assi\u00e9 G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida M, Barisson Fragoso MC, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, Benz C, Ally A, Balasundaram M, Bowlby R, Brooks D, Butterfield YSN, Carlsen R, Dhalla N, Guin R, Holt RA, Jones SJM, Kasaian K, Lee D, Li HI, Lim L, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ, Mungall K, Sadeghi S, Schein JE, Sipahimalani P, Tam A, Thiessen N, Park PJ, Kroiss M, Gao J, Sander C, Schultz N, Jones CD, Kucherlapati R, Mieczkowski PA, Parker JS, Perou CM, Tan D, Veluvolu U, Wilkerson MD, Hayes DN, Ladanyi M, Quinkler M, Auman JT, Latronico AC, Mendonca BB, Sibony M, Sanborn Z, Bellair M, Buhay C, Covington K, Dahdouli M, Dinh H, Doddapaneni H, Downs B, Drummond J, Gibbs R, Hale W, Han Y, Hawes A, Hu J, Kakkar N, Kalra D, Khan Z, Kovar C, Lee S, Lewis L, Morgan M, Morton D, Muzny D, Santibanez J, Xi L, Dousset B, Groussin L, Lib\u00e9 R, Chin L, Reynolds S, Shmulevich I, Chudamani S, Liu J, Lolla L, Wu Y, Yeh JJ, Balu S, Bodenheimer T, Hoyle AP, Jefferys SR, Meng S, Mose LE, Shi Y, Simons JV, Soloway MG, Wu J, Zhang W, Mills Shaw KR, Demchok JA, Felau I, Sheth M, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J(J), Davidsen T, Crawford C, Hutter CM, Sofia HJ, Roach J, Bshara W, Gaudioso C, Morrison C, Soon P, Alonso S, Baboud J, Pihl T, Raman R, Sun Q, Wan Y, Naresh R, Arachchi H, Beroukhim R, Carter SL, Cho J, Frazer S, Gabriel SB, Getz G, Heiman DI, Kim J, Lawrence MS, Lin P, Noble MS, Saksena G, Schumacher SE, Sougnez C, Voet D, Zhang H, Bowen J, Coppens S, Gastier-Foster JM, Gerken M, Helsel C, Leraas KM, Lichtenberg TM, Ramirez NC, Wise L, Zmuda E, Baylin S, Herman JG, LoBello J, Watanabe A, Haussler D, Radenbaugh A, Rao A, Zhu J, Bartsch DK, Sbiera S, Allolio B, Deutschbein T, Ronchi C, Raymond VM, Vinco M, Shao L, Amble L, Bootwalla MS, Lai PH, van den Berg DJ, Weisenberger DJ, Robinson B, Ju Z, Kim H, Ling S, Liu W, Lu Y, Mills GB, Sircar K, Wang Q, Yoshihara K, Laird PW, Fan Y, Wang W, Shinbrot E, Reincke M, Weinstein JN, Meier S, Defreitas T (2016) Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 29(5):723\u2013736","journal-title":"Cancer Cell"},{"issue":"1","key":"367_CR41","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41467-018-06366-z","volume":"9","author":"SK Gara","year":"2018","unstructured":"Gara SK, Lack J, Zhang L, Harris E, Cam M, Kebebew E (2018) Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors. Nat Commun 9(1):4172\u20134172","journal-title":"Nat Commun"},{"issue":"1","key":"367_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40425-018-0424-9","volume":"6","author":"L Tourneau","year":"2018","unstructured":"Tourneau L, Christophe CH, Zarwan C, Wong DJ, Bauer S, Claus R et al (2018) Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the Javelin Solid Tumor Trial. J Immunother Cancer 6(1):111\u2013111","journal-title":"J Immunother Cancer"},{"key":"367_CR43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2016.03.023","volume":"428","author":"F Beuschlein","year":"2016","unstructured":"Beuschlein F, Jakoby J, Mentz S, Zambetti G, Jung S, Reincke M, S\u00fcss R, Hantel C (2016) Igf1-R Inhibition and liposomal doxorubicin: progress in preclinical evaluation for the treatment of adrenocortical carcinoma. Mol Cell Endocrinol 428:82\u201388","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"367_CR44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","volume":"16","author":"M Fassnacht","year":"2015","unstructured":"Fassnacht M, Berruti A, Baudin E, Demeure MJ, Gilbert J, Haak H, Kroiss M, Quinn DI, Hesseltine E, Ronchi CL, Terzolo M, Choueiri TK, Poondru S, Fleege T, Rorig R, Chen J, Stephens AW, Worden F, Hammer GD (2015) Linsitinib (Osi-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Lancet Oncol 16(4):426\u2013435","journal-title":"Lancet Oncol"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-019-00367-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-019-00367-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-019-00367-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T17:28:52Z","timestamp":1609262932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-019-00367-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":44,"journal-issue":{"issue":"4-6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1007\/s12672-019-00367-0","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"25 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors confirm that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}